We are live on ! Find out more
DXCM icon

DexCom
DXCM

934 hedge funds and large institutions have $24.8B invested in DexCom in 2025 Q1 according to their latest regulatory filings, with 109 funds opening new positions, 375 increasing their positions, 314 reducing their positions, and 116 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more repeat investments, than reductions

Existing positions increased: 375 | Existing positions reduced: 314

19% more call options, than puts

Call options by funds: $401M | Put options by funds: $337M

1.45% more ownership

Funds ownership: 91.84% → 93.29% (+1.4%)

0% more funds holding in top 10

Funds holding in top 10: 7 → 7 (0)

6% less first-time investments, than exits

New positions opened: 109 | Existing positions closed: 116

2% less funds holding

Funds holding: 952 → 934 (-18)

11% less capital invested

Capital invested by funds: $27.9B → $24.8B (-$3.06B)

Holders
934
Holders Change
-18
Holders Change %
-1.89%
% of All Funds
12.5%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
109
Increased
375
Reduced
314
Closed
116
Calls
$401M
Puts
$337M
Net Calls
+$64M
Net Calls Change
-$164M

Top Buyers

Rank Fund Capital Flow
1
UBS AM
UBS AM
Illinois
+$239M
2
Jennison Associates
Jennison Associates
New York
+$235M
3
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$165M
4
Janus Henderson Group
Janus Henderson Group
+$164M
5
Federated Hermes
Federated Hermes
Pennsylvania
+$156M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$223M
2
Capital Research Global Investors
Capital Research Global Investors
California
-$191M
3
Citadel Advisors
Citadel Advisors
Florida
-$174M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$98.9M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$68.9M

DXCM Hedge Fund Activity: Q1 2025 in Review

934 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q1 2025, worth a combined $24.8B — down 11% from $27.9B a quarter earlier.

Sellers outnumbered buyers: 116 funds closed out of DXCM and 109 opened new positions — a net loss of 7 holders — while 314 trimmed existing stakes and 375 added.

The largest buyer was UBS AM, adding an estimated $239M. The largest seller was Millennium Management, cutting an estimated $223M.

  • 934 institutional investors held DexCom (DXCM) as of Q1 2025, down from 952 in Q4 2024.
  • Funds reported $24.8B of DexCom stock for Q1 2025, down 11% quarter-over-quarter.
  • 109 funds opened new DexCom positions in Q1 2025 and 116 closed out, a net change of -7 holders.
  • The largest DexCom buyer in Q1 2025 was UBS AM, an estimated $239M added.
  • The largest DexCom seller in Q1 2025 was Millennium Management, an estimated $223M sold.

Based on aggregated 13F filings for Q1 2025.